What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Cancer
- Gene
Emili Montserrat mainly investigates Internal medicine, Chronic lymphocytic leukemia, Oncology, Immunology and Lymphoma.
Her Internal medicine research integrates issues from Gastroenterology, Surgery and Pathology.
To a larger extent, Emili Montserrat studies Leukemia with the aim of understanding Chronic lymphocytic leukemia.
Her Oncology research includes themes of Clinical trial, Lymphocytic leukaemia, Lymphocyte and Doubling time.
She works mostly in the field of Immunology, limiting it down to topics relating to Cancer and, in certain cases, Lymph node biopsy, Biopsy and Disease progression.
The concepts of her Lymphoma study are interwoven with issues in Performance status and Consensus conference.
Her most cited work include:
- A predictive model for aggressive non-Hodgkin's lymphoma (3353 citations)
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines (2519 citations)
- International network of cancer genome projects (1611 citations)
What are the main themes of her work throughout her whole career to date?
The scientist’s investigation covers issues in Internal medicine, Chronic lymphocytic leukemia, Immunology, Oncology and Gastroenterology.
Internal medicine and Surgery are commonly linked in her work.
The Chronic lymphocytic leukemia study combines topics in areas such as Cancer research, Fludarabine and Minimal residual disease.
The study incorporates disciplines such as Cytogenetics and CD38 in addition to Immunology.
Her Oncology research is multidisciplinary, incorporating elements of Stage and Clinical trial.
As part of one scientific family, Emili Montserrat deals mainly with the area of Gastroenterology, narrowing it down to issues related to the Pathology, and often Immunophenotyping.
She most often published in these fields:
- Internal medicine (54.53%)
- Chronic lymphocytic leukemia (35.73%)
- Immunology (28.03%)
What were the highlights of her more recent work (between 2011-2021)?
- Chronic lymphocytic leukemia (35.73%)
- Internal medicine (54.53%)
- Oncology (23.76%)
In recent papers she was focusing on the following fields of study:
Emili Montserrat mostly deals with Chronic lymphocytic leukemia, Internal medicine, Oncology, Immunology and [email protected]
Her Chronic lymphocytic leukemia research includes elements of Disease and Minimal residual disease.
In her research, Pathology is intimately related to Immunophenotyping, which falls under the overarching field of Minimal residual disease.
Her study ties her expertise on Gastroenterology together with the subject of Internal medicine.
As part of the same scientific family, Emili Montserrat usually focuses on Oncology, concentrating on Transplantation and intersecting with Stem cell.
While the research belongs to areas of Immunology, Emili Montserrat spends her time largely on the problem of breakpoint cluster region, intersecting her research to questions surrounding Cancer research and B-cell receptor.
Between 2011 and 2021, her most popular works were:
- iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL (392 citations)
- ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia. (165 citations)
- ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL) (163 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
Her scientific interests lie mostly in Chronic lymphocytic leukemia, Internal medicine, Immunology, Leukemia and Oncology.
Her Chronic lymphocytic leukemia research incorporates themes from Cancer research, Disease, Pathology, Immunophenotyping and Transplantation.
She regularly links together related areas like Gastroenterology in her Internal medicine studies.
She combines subjects such as breakpoint cluster region and Stem cell with her study of Immunology.
Her work carried out in the field of Leukemia brings together such families of science as Antigen-presenting cell, Autoimmune hemolytic anemia, microRNA, Regulation of gene expression and Bruton's tyrosine kinase.
In Oncology, Emili Montserrat works on issues like Clinical trial, which are connected to Chemotherapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
